1. Mehra MR, Naka Y, Uriel N, et al. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. The New England journal of medicine. 2017;376:440-50.
2. Jabbar HR, Abbas A, Ahmed M, et al. The Incidence, Predictors and Outcomes of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device (LVAD). Digestive diseases and sciences. 2015;60:3697-706.
3. Shah R, Qayed E. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices. Southern medical journal. 2018;111:666-73.
4. Sparrow CT, Nassif ME, Raymer DS, et al. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. JACC Heart failure. 2015;3:956-64.
5. Yin MY, Ruckel S, Kfoury AG, et al. Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circulation Heart failure. 2018;11:e005267.
6. Geisen U, Heilmann C, Beyersdorf F, et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-84.
7. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-13.
8. Letsou GV, Shah N, Gregoric ID, et al. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2005;24:105-9.
9. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2011;30:849- 53.
10. Tabit CE, Chen P, Kim GH, et al. Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to AlteredAngiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016;134:141-52.
11. Tabit CE, Coplan MJ, Chen P, et al. Tumor necrosis factor-alpha levels and non- surgical bleeding in continuous-flow left ventricular assist devices. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37:107-15.
12. Nakamura M, Imamura T, Hori M, et al. Regulation of Angiopoietin-2 before and after Mechanical Circulatory Support Therapy. ASAIO J. 2020;In Press.
13. Patel SR, Madan S, Saeed O, et al. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices. JACC Heart failure. 2016;4:962-70.
14. Link A, Poss J, Rbah R, et al. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. European heart journal. 2013;34:1651-62.
15. Eleuteri E, Di Stefano A, Giordano A, et al. Prognostic value of angiopoietin-2 in patients with chronic heart failure. International journal of cardiology. 2016;212:364-8.
16. Ueland T, Gullestad L, Nymo SH, et al. Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta. 2015;443:71-7.
17. Van Linthout S, Tschope C. Inflammation - Cause or Consequence of Heart Failure or Both? Curr Heart Fail Rep. 2017;14:251-65.
18. Bartoli CR, Kang J, Zhang D, et al. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System. The Annals of thoracic surgery. 2017;103:1239-44.
19. Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave. European heart journal. 2019;40:673-7.
20. Nayak A, Neill C, Kormos RL, et al. Chemokine receptor patterns and right heart failure in mechanical circulatory support. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017;36:657-65.
21. Tang PC, Haft JW, Romano MA, et al. Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro- inflammatory response. J Cardiothorac Surg. 2019;14:80.
22. Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci.2015;1347:45-51.
23. Imamura T, Jeevanandam V, Kim G, et al. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circulation Heart failure. 2019;12:e005094.
24. Imamura T, Nguyen A, Rodgers D, et al. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circulation Heart failure. 2018;11:e005082.
25. Vukelic S, Vlismas PP, Patel SR, et al. Digoxin Is Associated With a Decreased Incidence of Angiodysplasia-Related Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices. Circulation Heart failure. 2018;11:e004899.